COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- In vitro, antioxidant activities of aqueous and methanol roselle (Hibiscus sabdariffa) calyces extracts from two localities in Cameroon
- Diet, weight status, and physical activity in cancer prevention
- Bioenrichment using Satureja montana L. essential oil for the prevention against photooxidation of flavored extra virgin olive oil during light display
- Cross‐sectional association between lifestyle behavior and cardiometabolic biomarkers in west Algerian postmenopausal women
- Effect of healthy lifestyle promotion on anthropometric variables, eating behavior and cardiometabolic risk factors in women with polycystic ovarian syndrome
- Update of the Nutrition Situation in Nigeria
- Prevalence of type 2 diabetes mellitus in Africa: an updated narrative review
- Update of the nutritional situation in Benin Republic
- Food and Water Security in Developing Economies: Impact of Pandemic and Possible Interventions
- Mold Chitosan production using Ficus microcarpa fruit
You may also start an advanced similarity search for this article.

NAJFNR is licensed under